资讯
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study Osteosarcoma (OS) is the most ...
The XGBoost-based approach demonstrated robust external validation across multiple centers, supporting clinical adoption to guide personalized treatment decisions.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈